<HTML>
<HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">
<DIV style="font-size: 10pt">
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND
EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest
event reported): March 25, 2009</B>

<P style="font-size: 24pt" align="center"><B>The Spectranetics
Corporation<BR>
</B><FONT style="font-size: 10pt">(Exact name of registrant as
specified in its charter) </FONT>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Delaware</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>000-19711</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>84-0997049</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>

</TABLE>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>9965 Federal
Drive<BR>
Colorado Springs, Colorado<BR>
</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>80921</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number,
including area code: <B>(719) 633-8333</B>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="30%" border="0">

 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>&nbsp;</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<DIV
style="margin-top: 10pt; font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="left"><B>Item&nbsp;1.01. Entry Into a
Material Definitive Agreement.</B>

<P style="font-size: 10pt; text-indent: 4%" align="left">On March&nbsp;25,
2009, the Spectranetics Corporation (the &#8220;Company&#8221;) entered into a
consulting agreement (the &#8220;Agreement&#8221;) with Dr.&nbsp;Craig Walker,
a member of the Company&#8217;s board of directors, pursuant to which
Dr.&nbsp;Walker trains physicians in the use of the Company&#8217;s excimer
laser and other non-laser technology related to the treatment of peripheral
vascular disease. In addition, the agreement provides for project consulting
and educational services, which include speaker honoraria and directing or
moderating Master Summit laser training courses. These training and consulting
fees are pre-established at the rate of $300 per hour, subject to maximums
associated with each type of engagement, and are subject to pre-approval of
authorized Spectranetics employees. The term of the Agreement is from
March&nbsp;9, 2009 to March&nbsp;9, 2010. The Agreement is attached hereto as
Exhibit&nbsp;10.1 to this Current Report on Form 8-K and incorporated herein by
reference.

<P style="font-size: 10pt" align="left"><B>ITEM 9.01 Financial Statements and
Exhibits.</B>

<P style="font-size: 10pt; margin-left: 2%" align="left">(d)&nbsp;Exhibits

<P>
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">

 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD style="background: none transparent scroll repeat 0% 0%"
width="4%">&nbsp;</TD>
  <TD nowrap align="left" width="3%">10.1</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>Consulting Agreement between The Spectranetics Corporation and Craig M.
Walker, MD, dated March&nbsp;25, 2009.</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P>
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">

</TABLE>


<P style="font-size: 10pt" align="center">SIGNATURES

<P style="font-size: 10pt; text-indent: 4%" align="left">Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.

<P style="font-size: 10pt; margin-left: 45%" align="left">THE SPECTRANETICS
<BR>
CORPORATION

<P style="font-size: 10pt" align="left">Date: March&nbsp;31, 2009

<P style="margin-top: -11pt; font-size: 10pt; margin-left: 45%"
align="left">By: <U><B>/</B>s/ Guy A.
Childs&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
<BR>
Guy A. Childs <BR>
Chief Financial Officer <BR>
(Principal Financial and
Accounting Officer)

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><B>EXHIBIT INDEX</B>

<P style="font-size: 10pt" align="left"><U>Exhibit&nbsp;No.</U>

<P>
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">

 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD nowrap align="left" width="3%">10.1</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>Consulting Agreement between The Spectranetics Corporation and Craig M.
Walker, MD, dated March&nbsp;25, 2009.</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">4
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c83232e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 8234}]
{"company-data": {"conformed-name": "SPECTRANETICS CORP", "cik": "0000789132", "assigned-sic": "3845", "irs-number": "840997049", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-19711", "film-number": "09716496"}, "business-address": {"street1": "96 TALAMINE COURT", "city": "COLORADO SPRING", "state": "CO", "zip": "80907", "phone": "7196338333"}, "mail-address": {"street1": "96 TALAMINE COURT", "city": "COLORADO SPRINGS", "state": "CO", "zip": "80907"}, "former-company": {"former-conformed-name": "THE SPECTRANETICS CORP", "date-changed": "19900510"}}
Form 8-K
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): March 25, 2009
The Spectranetics
Corporation
(Exact name of registrant as
specified in its charter)
Delaware
000-19711
84-0997049
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
9965 Federal
Drive
Colorado Springs, Colorado
80921
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number,
including area code:
(719) 633-8333
(Former name or former address if changed since last report.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry Into a
Material Definitive Agreement.
On March 25,
2009, the Spectranetics Corporation (the "Company") entered into a
consulting agreement (the "Agreement") with Dr. Craig Walker,
a member of the Company's board of directors, pursuant to which
Dr. Walker trains physicians in the use of the Company's excimer
laser and other non-laser technology related to the treatment of peripheral
vascular disease. In addition, the agreement provides for project consulting
and educational services, which include speaker honoraria and directing or
moderating Master Summit laser training courses. These training and consulting
fees are pre-established at the rate of $300 per hour, subject to maximums
associated with each type of engagement, and are subject to pre-approval of
authorized Spectranetics employees. The term of the Agreement is from
March 9, 2009 to March 9, 2010. The Agreement is attached hereto as
Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by
reference.
ITEM 9.01 Financial Statements and
Exhibits.
(d) Exhibits
10.1
Consulting Agreement between The Spectranetics Corporation and Craig M.
Walker, MD, dated March 25, 2009.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
THE SPECTRANETICS
CORPORATION
Date: March 31, 2009
By:
/
s/ Guy A.
Childs
Guy A. Childs
Chief Financial Officer
(Principal Financial and
Accounting Officer)
EXHIBIT INDEX
Exhibit No.
10.1
Consulting Agreement between The Spectranetics Corporation and Craig M.
Walker, MD, dated March 25, 2009.